WEED Australia Ltd. is Honored to be Invited and Attend the United in Compassion 2022 Australian Medicinal Cannabis Symposium!

WEED Australia Ltd., w/non-profit arm, The Cannabis Institute of Australia, is attending the United in Compassion Australian Medicinal Cannabis Symposium May 20-22, 2022 on the sunshine coast in northern Queensland.

TUCSON, AZ / ACCESSSWIRE / May 4, 2022 / WEED, Inc. (OTCQB:BUDZ) (OTCMarkets.com), is a multi-national, multi-faceted, vertically integrated global Cannabis holding company focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases. WEED Australia Ltd., created by WEED, Inc. and billed as "America's First Public Cannabis Company Down Under" is attending the United in Compassion Australian Medicinal Cannabis Symposium May 20-22 in Queensland, Australia. WEED, Inc.'s Chairman and CEO, Glenn E. Martin, will represent WEED, Inc. along with Patrick Brodnik, Managing Director of WEED Australia Ltd. at this exclusive event. WEED plans to meet with global leaders in the cannabis industry worldwide to discuss joint ventures and strategic partnerships.

Foto: Accesswire

Keynote speakers for this event include. Dr. Raphael Mechoulam of Hebrew University in Jerusalem (HUJ), Dr. Sue Sisley of Arizona, who received one of the 7 DEA research licenses last year, concentrating on utilizing cannabis to lessen pain & stress for our Veterans. Beloved Australians and medical cannabis leaders Olivia Newton-John & John Easterling have also announced they are planning to be in attendance at the conference.

This event is the fifth United in Compassion (UIC) Symposium of its type in Australia, which began as a patient-led movement created by Daniel Haslam's mother, Lucy Haslam. It was a driving factor in changing Australian law and inspired a new industry for the benefit of Australian patients. Called Dan's Law, it was put in place to legalize the cultivation of medicinal cannabis in Australia.

UIC's focus remains on patients providing them with better education on alternative medicines, such as cannabis & hemp, improving and informing the health workforce on the benefits of cannabis and promoting the development of a viable, professional and patient-focused industry.

Patients, clinicians, researchers in the cannabis industry come together to discuss exciting developments and to hear from renowned experts from home and from around the globe.

Patrick Brodnik, WEED Australia's Managing Director commented, "The current legal framework around medicinal cannabis in Australia is still evolving and remains tightly restricted by the ODC (Office of Drug Control) but patient numbers are rapidly increasing. The TGA (Therapeutic Goods Administration) is streamlining the application process for medicinal cannabis patients and doctors alike. These special access scheme applications can now be lodged online. As one of WEED's representative, I hope to provide information concerning many of the medical Cannabis issues that Australia faces."